A detailed history of Td Waterhouse Canada Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 51,465 shares of ABBV stock, worth $9.11 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
51,465
Previous 71,902 28.42%
Holding current value
$9.11 Million
Previous $12.3 Billion 17.31%
% of portfolio
0.08%
Previous 0.11%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$163.84 - $199.33 $3.35 Million - $4.07 Million
-20,437 Reduced 28.42%
51,465 $10.1 Billion
Q2 2024

Nov 12, 2024

BUY
$154.79 - $180.76 $154,944 - $180,940
1,001 Added 1.41%
71,902 $12.3 Billion
Q2 2024

Aug 02, 2024

BUY
$154.79 - $180.76 $34,363 - $40,128
222 Added 0.31%
70,901 $16.1 Billion
Q1 2024

May 10, 2024

SELL
$159.82 - $182.1 $1.31 Million - $1.49 Million
-8,206 Reduced 10.4%
70,679 $13.3 Billion
Q4 2023

Feb 12, 2024

SELL
$137.6 - $154.97 $2.11 Million - $2.38 Million
-15,369 Reduced 16.31%
78,885 $13.3 Billion
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $632,281 - $731,958
-4,733 Reduced 4.78%
94,254 $14.4 Billion
Q2 2023

Nov 13, 2023

SELL
$132.51 - $164.9 $12.5 Million - $15.5 Million
-94,142 Reduced 48.75%
98,987 $13.9 Billion
Q1 2023

Nov 13, 2023

BUY
$144.61 - $166.54 $3.7 Million - $4.26 Million
25,577 Added 15.27%
193,129 $31.8 Billion
Q4 2022

Nov 13, 2023

BUY
$138.31 - $165.87 $82,571 - $99,024
597 Added 0.36%
167,552 $27.9 Billion
Q3 2022

Nov 13, 2023

SELL
$134.21 - $153.93 $6.7 Million - $7.69 Million
-49,940 Reduced 23.02%
166,955 $23.6 Billion
Q2 2022

Nov 13, 2023

SELL
$137.62 - $174.96 $4.31 Million - $5.48 Million
-31,330 Reduced 12.62%
216,895 $34 Billion
Q1 2022

Nov 13, 2023

BUY
$131.98 - $163.75 $1.44 Million - $1.78 Million
10,873 Added 4.58%
248,225 $39.7 Billion
Q4 2021

Nov 13, 2023

BUY
$107.43 - $135.93 $25.5 Million - $32.3 Million
237,352 New
237,352 $31.7 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Td Waterhouse Canada Inc. Portfolio

Follow Td Waterhouse Canada Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

News

Stay updated on Td Waterhouse Canada Inc. with notifications on news.